Related references
Note: Only part of the references are listed.The Angiopoietin-Like Protein 3 and 8 Complex Interacts with Lipoprotein Lipase and Induces LPL Cleavage
Najia Jin et al.
ACS CHEMICAL BIOLOGY (2021)
Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3
Min Qiu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
ANGPTL3 gene variants in subjects with familial combined hyperlipidemia
A. M. Bea et al.
SCIENTIFIC REPORTS (2021)
Angiopoietin-like proteins as therapeutic targets for cardiovascular disease: focus on lipid disorders
Marco Bruno Morelli et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2020)
A novel NanoBiT-based assay monitors the interaction between lipoprotein lipase and GPIHBP1 in real time
Shwetha K. Shetty et al.
JOURNAL OF LIPID RESEARCH (2020)
Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: New therapeutic approaches for the treatment of atherogenic dyslipidemia
Massimiliano Ruscica et al.
PHARMACOLOGICAL RESEARCH (2020)
Triglyceride metabolism and angiopoietin-like proteins in lipoprotein lipase regulation
Jing Li et al.
CLINICA CHIMICA ACTA (2020)
Treating Dyslipidemias in the Primary Prevention of Atherosclerotic Cardiovascular Disease in Older Adults with Diabetes Mellitus
MengHee Tan et al.
CLINICS IN GERIATRIC MEDICINE (2020)
Triglycerides and ASCVD Risk Reduction: Recent Insights and Future Directions
Aliza Hussain et al.
CURRENT ATHEROSCLEROSIS REPORTS (2020)
Angiopoietin-like protein 3 governs LDL-cholesterol levels through endothelial lipase-dependent VLDL clearance
Rene C. Adam et al.
JOURNAL OF LIPID RESEARCH (2020)
Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to ANGPTL3 mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemia
Daniel Gaudet et al.
EUROPEAN HEART JOURNAL (2020)
Evinacumab for Homozygous Familial Hypercholesterolemia
Frederick J. Raal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
GALNT2 regulates ANGPTL3 cleavage in cells and in vivo of mice
Xuedan Li et al.
SCIENTIFIC REPORTS (2020)
Statin therapy reduces plasma angiopoietin-like 3 (ANGPTL3) concentrations in hypercholesterolemic patients via reduced liver X receptor (LXR) activation
Laurens F. Reeskamp et al.
ATHEROSCLEROSIS (2020)
ANGPTL3 Mutations in Unrelated Chinese Han Patients with Familial Hypercholesterolemia
Yunyun Yang et al.
CURRENT PHARMACEUTICAL DESIGN (2019)
Metabolomic Signature of Angiopoietin-Like Protein 3 Deficiency in Fasting and Postprandial State
Emmi Tikkanen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
GPIHBP1 and Lipoprotein Lipase, Partners in Plasma Triglyceride Metabolism
Stephen G. Young et al.
CELL METABOLISM (2019)
Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia
Zahid Ahmad et al.
CIRCULATION (2019)
Lipoprotein lipase: new roles for an 'old' enzyme
Chuchun L. Chang
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2019)
ANGPTL3: a novel biomarker and promising therapeutic target
Shuang Jiang et al.
JOURNAL OF DRUG TARGETING (2019)
Obesity and dyslipidemia
Jelena Vekic et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Angiopoietin-Like 3 From Discovery to Therapeutic Gene Editing
Xiao Wang et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2019)
Reduced Blood Lipid Levels With In Vivo CRISPR-Cas9 Base Editing of ANGPTL3
Alexandra C. Chadwick et al.
CIRCULATION (2018)
In vivo genome editing of ANGPTL3: a therapy for atherosclerosis?
June-Wha Rhee et al.
NATURE REVIEWS CARDIOLOGY (2018)
Novel Therapeutic Targets for Managing Dyslipidemia
Vasanth Sathiyakumar et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Structures of Angptl3 and Angptl4, modulators of triglyceride levels and coronary artery disease
Ekaterina Biterova et al.
SCIENTIFIC REPORTS (2018)
Angiopoietin-like protein 3 and 4 in obesity, type 2 diabetes mellitus, and malnutrition: the effect of weight reduction and realimentation
Anna Cinkajzlova et al.
NUTRITION & DIABETES (2018)
Threshold Effects of Circulating Angiopoietin-Like 3 Levels on Plasma Lipoproteins
Sergio Fazio et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearance
Jorge F. Haller et al.
JOURNAL OF LIPID RESEARCH (2017)
ANGPTL3 Deficiency and Protection Against Coronary Artery Disease
Nathan O. Stitziel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Angiopoietin-like 3 in lipoprotein metabolism
Sander Kersten
NATURE REVIEWS ENDOCRINOLOGY (2017)
Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides
Mark J. Graham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease
F. E. Dewey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase
Xun Chi et al.
MOLECULAR METABOLISM (2017)
New approaches to address dyslipidemia
Klaus G. Parhofer
CURRENT OPINION IN LIPIDOLOGY (2017)
Loss of Function of GALNT2 Lowers High-Density Lipoproteins in Humans, Nonhuman Primates, and Rodents
Sumeet A. Khetarpal et al.
CELL METABOLISM (2016)
Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease New Insights From Epidemiology, Genetics, and Biology
Borge G. Nordestgaard
CIRCULATION RESEARCH (2016)
Surprises From Genetic Analyses of Lipid Risk Factors for Atherosclerosis
Kiran Musunuru et al.
CIRCULATION RESEARCH (2016)
Role of lipoprotein lipase in lipid metabolism
Gunilla Olivecrona
CURRENT OPINION IN LIPIDOLOGY (2016)
The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking
Ren Zhang
OPEN BIOLOGY (2016)
Regulation of Angiopoietin-Like Proteins (ANGPTLs) 3 and 8 by Insulin
P. A. Nidhina Haridas et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
ANGPTL3 blockade with a human monoclonal antibody reduces plasma lipids in dyslipidemic mice and monkeys
Viktoria Gusarova et al.
JOURNAL OF LIPID RESEARCH (2015)
Management of patients with familial hypercholesterolaemia
Zeljko Reiner
NATURE REVIEWS CARDIOLOGY (2015)
Hepatic ANGPTL3 regulates adipose tissue energy homeostasis
Yan Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Differential Association of Plasma Angiopoietin-Like Proteins 3 and 4 With Lipid and Metabolic Traits
Nidhi Mehta et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Angptl3 Deficiency Is Associated With Increased Insulin Sensitivity, Lipoprotein Lipase Activity, and Decreased Serum Free Fatty Acids
Marius R. Robciuc et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Furin Is the Primary in Vivo Convertase of Angiopoietin-like 3 and Endothelial Lipase in Hepatocytes
Rachid Essalmani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Characterization of Three Kindreds With Familial Combined Hypolipidemia Caused by Loss-of-Function Mutations of ANGPTL3
Livia Pisciotta et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2012)
Mutations in the ANGPTL3 Gene and Familial Combined Hypolipidemia: A Clinical and Biochemical Characterization
Ilenia Minicocci et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Atypical angiopoietin-like protein that regulates ANGPTL3
Fabiana Quagliarini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Modulation of plasma TG lipolysis by Angiopoietin-like proteins and GPIHBP1
Laeticia Lichtenstein et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)
GPIHBP1 Is Responsible for the Entry of Lipoprotein Lipase into Capillaries
Brandon S. J. Davies et al.
CELL METABOLISM (2010)
AngptI4 Protects against Severe Proinflammatory Effects of Saturated Fat by Inhibiting Fatty Acid Uptake into Mesenteric Lymph Node Macrophages
Laeticia Lichtenstein et al.
CELL METABOLISM (2010)
O-Glycosylation Modulates Proprotein Convertase Activation of Angiopoietin-like Protein 3 POSSIBLE ROLE OF POLYPEPTIDE GalNAc-TRANSFERASE-2 IN REGULATION OF CONCENTRATIONS OF PLASMA LIPIDS
Katrine T. -B. G. Schjoldager et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Angiopoietin-like Protein 3 Inhibits Lipoprotein Lipase Activity through Enhancing Its Cleavage by Proprotein Convertases
Jun Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Exome Sequencing, ANGPTL3 Mutations, and Familial Combined Hypolipidemia
Kiran Musunuru et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
A polygenic basis for four classical Fredrickson hyperlipoproteinemia phenotypes that are characterized by hypertriglyceridemia
Robert A. Hegele et al.
HUMAN MOLECULAR GENETICS (2009)
Identification of a New Functional Domain in Angiopoietin-like 3 (ANGPTL3) and Angiopoietin-like 4 (ANGPTL4) Involved in Binding and Inhibition of Lipoprotein Lipase (LPL)
E-Chiang Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans
Stefano Romeo et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Newly identified loci that influence lipid concentrations and risk of coronary artery disease
Cristen J. Willer et al.
NATURE GENETICS (2008)
Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans
Sekar Kathiresan et al.
NATURE GENETICS (2008)
Hepatic proprotein convertases modulate HDL metabolism
Weijun Jin et al.
CELL METABOLISM (2007)
Lipid-lowering effects of anti-angiopoietin-like 4 antibody recapitulate the lipid phenotype found in angiopoietin-like 4 knockout mice
Urvi Desai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The lipoprotein lipase inhibitor ANGPTL3 is negatively regulated by thyroid hormone
C Fugier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
ANGPTL3 is increased in both insulin-deficient and -resistant diabetic states
K Inukai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Protein region important for regulation of lipid metabolism in angiopoietin-like 3 (ANGPTL3) -: ANGPTL3 is cleaved and activated in vivo
M Ono et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver X receptor
T Inaba et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Angptl3 regulates lipid metabolism in mice
R Koishi et al.
NATURE GENETICS (2002)
Share Paper
